DNA Methylation Signatures Correlate with Response to Immune Checkpoint Inhibitors in Metastatic Melanoma.

Target Oncol · 2024 · PMC10963567 · PMID 38401029

Europe PMC DOI

hedged sentence

0.0887

closest p · 1.8× alpha

0.0887

boldest claim

The sentences

showed a trendp = 0.0887so close (0.05 < p ≤ 0.1)

A further exploratory analysis revealed that non-responders compared with responders showed a trend towards a higher ECOG status ≥1 ( p = 0.0887), albeit not significant, and no differences between non-responders and responders in baseline LDH ( p = 0.6646) and S100 levels ( p = 0.7500) were observed.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.